BeOne Medicines Ltd. - Sponsored ADR (ONC) vs Vertex Pharmaceuticals Incorporated (VRTX)

BeOne Medicines Ltd. - Sponsored ADR and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $137.5B against $40.4B — 3.4× the size. Vertex Pharmaceuticals Incorporated trades at the lower P/E: 34.6× against 65.9×. BeOne Medicines Ltd. - Sponsored ADR grew revenue faster over the last twelve months: 32.9% against 10.5%. Vertex Pharmaceuticals Incorporated has the higher net margin (30.7% vs 13.9%) and the lower return on invested capital (14.9% vs 85.2%). Across the 22 metrics below, BeOne Medicines Ltd. - Sponsored ADR leads on 12 and Vertex Pharmaceuticals Incorporated on 10.

Valuation

Metric ONC VRTX Biotechnology median
P/E 65.91 34.57 10.26
P/S 6.57 10.60 9.18
P/B 7.45 6.57 2.05
Price to free cash flow 30.36 42.87 24.81
EV/EBITDA 28.56 29.68 0.65
EV/Sales 5.87 10.41 8.98
Earnings yield 1.52% 2.89% (34.89%)
Free cash flow yield 3.29% 2.33% (24.52%)

Profitability

Metric ONC VRTX Biotechnology median
Gross margin 89.39% 85.53% 65.16%
Operating margin 17.84% 33.23% 0.00%
Net margin 13.86% 30.70% 0.00%
Free cash flow margin 21.94% 24.73% 0.00%
Return on equity 18.40% 20.80% (50.12%)
Return on assets 10.46% 13.81% (45.60%)
Return on invested capital 85.21% 14.86% 0.00%

Growth

Metric ONC VRTX Biotechnology median
Revenue growth (TTM) 32.86% 10.48% 6.26%
EPS growth (last fiscal year) 141.34% 836.54% 29.88%
Revenue growth, 5-year CAGR 76.85% 14.10% 9.75%
Net income growth, 5-year CAGR 0.00% 7.83% 0.00%

Health

Metric ONC VRTX Biotechnology median
Debt to equity 0.14 0.17 0.00
Current ratio 3.55 2.34 4.89
Net debt to EBITDA (6.09) (1.51) 1.01

Dividend

Metric ONC VRTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ONC VRTX Biotechnology median
Market cap 40.38b 137.54b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack